These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33158511)

  • 1. The impact of tumor fragmentation in patients with stage I uterine leiomyosarcoma on patterns of recurrence and oncologic outcome.
    Pedra Nobre S; Hensley ML; So M; Zhou QC; Iasonos A; Leitao MM; Ducie J; Chiang S; Mueller JJ; Abu-Rustum NR; Zivanovic O
    Gynecol Oncol; 2021 Jan; 160(1):99-105. PubMed ID: 33158511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of re-exploration in patients with inadvertently morcellated uterine sarcoma.
    Oduyebo T; Rauh-Hain AJ; Meserve EE; Seidman MA; Hinchcliff E; George S; Quade B; Nucci MR; Del Carmen MG; Muto MG
    Gynecol Oncol; 2014 Feb; 132(2):360-5. PubMed ID: 24296345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective cohort study evaluating the impact of intraperitoneal morcellation on outcomes of localized uterine leiomyosarcoma.
    George S; Barysauskas C; Serrano C; Oduyebo T; Rauh-Hain JA; Del Carmen MG; Demetri GD; Muto MG
    Cancer; 2014 Oct; 120(20):3154-8. PubMed ID: 24923260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of tumor morcellation during surgery on the prognosis of patients with apparently early uterine leiomyosarcoma.
    Park JY; Park SK; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
    Gynecol Oncol; 2011 Aug; 122(2):255-9. PubMed ID: 21565389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of morcellation on survival outcomes of patients with unexpected uterine leiomyosarcoma: a systematic review and meta-analysis.
    Bogani G; Cliby WA; Aletti GD
    Gynecol Oncol; 2015 Apr; 137(1):167-72. PubMed ID: 25462199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcome affected by tumor morcellation in unexpected early uterine leiomyosarcoma.
    Lin KH; Torng PL; Tsai KH; Shih HJ; Chen CL
    Taiwan J Obstet Gynecol; 2015 Apr; 54(2):172-7. PubMed ID: 25951723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occult Uterine Sarcoma and Leiomyosarcoma: Incidence of and Survival Associated With Morcellation.
    Raine-Bennett T; Tucker LY; Zaritsky E; Littell RD; Palen T; Neugebauer R; Axtell A; Schultze PM; Kronbach DW; Embry-Schubert J; Sundang A; Bischoff K; Compton-Phillips AL; Lentz SE
    Obstet Gynecol; 2016 Jan; 127(1):29-39. PubMed ID: 26646120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uterine morcellation and survival in uterine sarcomas.
    Bretthauer M; Goderstad JM; Løberg M; Emilsson L; Ye W; Adami HO; Kalager M
    Eur J Cancer; 2018 Sep; 101():62-68. PubMed ID: 30025231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignancy rate of 10,731 uteri morcellated during laparoscopic supracervical hysterectomy (LASH).
    Bojahr B; De Wilde RL; Tchartchian G
    Arch Gynecol Obstet; 2015 Sep; 292(3):665-72. PubMed ID: 25820974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of adjuvant treatment for morcellated, International Federation of Gynecology and Obstetrics stage I uterine leiomyosarcoma: A Korean multicenter study.
    Kim SI; Choi CH; Kim K; Hong DH; Park JY; Kwon BS; Lee KH; Hong DG; Shin SJ; Park SI; Kim YH; Lee SH; Lee S; Hong JH; Lee JY; Kim YB; No JH; Suh DH
    J Obstet Gynaecol Res; 2020 Feb; 46(2):337-346. PubMed ID: 31814199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidental power morcellation of malignancy: a retrospective cohort study.
    Graebe K; Garcia-Soto A; Aziz M; Valarezo V; Heller PB; Tchabo N; Tobias DH; Salamon C; Ramieri J; Dise C; Slomovitz BM
    Gynecol Oncol; 2015 Feb; 136(2):274-7. PubMed ID: 25740603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Multicentre Retrospective Review of Clinical Characteristics of Uterine Sarcoma.
    Wais M; Tepperman E; Bernardini MQ; Gien LT; Jimenez W; Murji A
    J Obstet Gynaecol Can; 2017 Aug; 39(8):652-658. PubMed ID: 28729098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. External validation of a prognostic nomogram for overall survival in women with uterine leiomyosarcoma.
    Iasonos A; Keung EZ; Zivanovic O; Mancari R; Peiretti M; Nucci M; George S; Colombo N; Carinelli S; Hensley ML; Raut CP
    Cancer; 2013 May; 119(10):1816-22. PubMed ID: 23456762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncological outcomes of unexpected uterine leiomyosarcoma: A single-center retrospective analysis of 5528 consecutive hysterectomies.
    Casarin J; Ghezzi F; Lembo A; Artuso V; Schivardi G; Galati EF; Ambrosoli AL; Bogani G; Multinu F; Cromi A
    J Surg Oncol; 2024 Mar; 129(3):517-522. PubMed ID: 37974522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of stage I occult uterine leiomyosarcoma: effects of morcellation, second-look surgery, and adjuvant treatments on survival.
    Yang J; Yang J; Cao D; Pan L; Wu M; Xiang Y
    Ann Transl Med; 2022 Jan; 10(2):127. PubMed ID: 35282058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Surgery on the Evolution of Uterine Sarcomas.
    Cusidó M; Fargas F; Baulies S; Plana A; Rodríguez I; Tresserra F; Pascual MA; Fábregas R
    J Minim Invasive Gynecol; 2015; 22(6):1068-74. PubMed ID: 26070730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-bag manual versus uncontained power morcellation for laparoscopic myomectomy.
    Zullo F; Venturella R; Raffone A; Saccone G
    Cochrane Database Syst Rev; 2020 May; 5(5):CD013352. PubMed ID: 32374421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes and prognostic markers in uterine leiomyosarcoma: a population-based cohort.
    Garcia C; Kubat JS; Fulton RS; Anthony AT; Combs M; Powell CB; Littell RD
    Int J Gynecol Cancer; 2015 May; 25(4):622-8. PubMed ID: 25675041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laparoscopic Hysterectomy for Uterine Fibroids: Is it Safe?
    Hinchcliff EM; Cohen SL
    Clin Obstet Gynecol; 2016 Mar; 59(1):66-72. PubMed ID: 26670837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritoneal dissemination complicating morcellation of uterine mesenchymal neoplasms.
    Seidman MA; Oduyebo T; Muto MG; Crum CP; Nucci MR; Quade BJ
    PLoS One; 2012; 7(11):e50058. PubMed ID: 23189178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.